Currently, there are 5.37B common shares owned by the public and among those 5.37B shares have been available to trade.
The company’s stock has a 5-day price change of 2.00% and -5.15% over the past three months. NOK shares are trading 3.84% year to date (YTD), with the 12-month market performance up to 25.00% higher. It has a 12-month low price of $3.29 and touched a high of $4.95 over the same period. NOK has an average intraday trading volume of 16.40 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.13%, 4.01%, and 10.84% respectively.
Institutional ownership of Nokia Corp ADR (NYSE: NOK) shares accounts for 7.62% of the company’s 5.37B shares outstanding.
It has a market capitalization of $24.72B and a beta (3y monthly) value of 1.07. The stock’s trailing 12-month PE ratio is 18.42, while the earnings-per-share (ttm) stands at $0.25. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.56% over the week and 1.73% over the month.
Analysts forecast that Nokia Corp ADR (NOK) will achieve an EPS of 0.06 for the current quarter, 0.07 for the next quarter and 0.36 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.04 while analysts give the company a high EPS estimate of 0.04. Comparatively, EPS for the current quarter was 0.1 a year ago. Earnings per share for the fiscal year are expected to decrease by -17.96%, and 10.35% over the next financial year. EPS should shrink at an annualized rate of -0.91% over the next five years, compared to 317.04% over the past 5-year period.
Looking at the support for the NOK, a number of firms have released research notes about the stock. Goldman stated their Sell rating for the stock in a research note on January 16, 2025, with the firm’s price target at $3.60. JP Morgan coverage for the Nokia Corp ADR (NOK) stock in a research note released on December 09, 2024 offered a Overweight rating with a price target of $6.35. Exane BNP Paribas on their part issued Neutral rating on January 12, 2024.
